Phase I Study of Pacritinib and Chemotherapy in Patients With Acute Myeloid Leukemia and FLT3 Mutations
Phase of Trial: Phase I
Latest Information Update: 11 Jul 2017
At a glance
- Drugs Pacritinib (Primary) ; Cytarabine; Daunorubicin; Decitabine
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 06 Jul 2017 Status changed from recruiting to suspended as per FDA.
- 10 Jun 2017 Biomarkers information updated
- 28 Jun 2016 Status changed from not yet recruiting to recruiting.